Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

This study is currently recruiting participants.

Study NCT00807859 Information provided by Amgen

First Received: December 11, 2008 Last Updated: November 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	March 2012
Estimated Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)